AU2007272576B2 - 6, 9-disubstituted purine derivatives and their use for treating skin - Google Patents

6, 9-disubstituted purine derivatives and their use for treating skin Download PDF

Info

Publication number
AU2007272576B2
AU2007272576B2 AU2007272576A AU2007272576A AU2007272576B2 AU 2007272576 B2 AU2007272576 B2 AU 2007272576B2 AU 2007272576 A AU2007272576 A AU 2007272576A AU 2007272576 A AU2007272576 A AU 2007272576A AU 2007272576 B2 AU2007272576 B2 AU 2007272576B2
Authority
AU
Australia
Prior art keywords
skin
cells
purine
tetrahydropyranyl
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007272576A
Other languages
English (en)
Other versions
AU2007272576A1 (en
Inventor
Karel Dolezal
Ludek Frohlich
Frank J. Massino
Lukas Spichal
Miroslav Strnad
Lucie Szucova
Marek Zatloukal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Experimental Botany Academy CAS
Original Assignee
Institute of Experimental Botany Academy CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Experimental Botany Academy CAS filed Critical Institute of Experimental Botany Academy CAS
Publication of AU2007272576A1 publication Critical patent/AU2007272576A1/en
Application granted granted Critical
Publication of AU2007272576B2 publication Critical patent/AU2007272576B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU2007272576A 2006-07-10 2007-07-10 6, 9-disubstituted purine derivatives and their use for treating skin Ceased AU2007272576B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80687106P 2006-07-10 2006-07-10
US60/806,871 2006-07-10
US11/774,652 US20080009508A1 (en) 2006-07-10 2007-07-09 6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
US11/774,652 2007-07-09
PCT/US2007/073142 WO2008008770A2 (en) 2006-07-10 2007-07-10 6, 9-disubstituted purine derivatives and their use for treating skin

Publications (2)

Publication Number Publication Date
AU2007272576A1 AU2007272576A1 (en) 2008-01-17
AU2007272576B2 true AU2007272576B2 (en) 2012-05-17

Family

ID=38919793

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007272576A Ceased AU2007272576B2 (en) 2006-07-10 2007-07-10 6, 9-disubstituted purine derivatives and their use for treating skin

Country Status (16)

Country Link
US (4) US20080009508A1 (enExample)
EP (1) EP2043630B1 (enExample)
JP (1) JP5309023B2 (enExample)
KR (1) KR101478727B1 (enExample)
CN (1) CN101646435B (enExample)
AU (1) AU2007272576B2 (enExample)
BR (1) BRPI0714161A2 (enExample)
CA (1) CA2657516C (enExample)
EA (1) EA015848B1 (enExample)
ES (1) ES2603216T3 (enExample)
IL (1) IL196442A (enExample)
MX (1) MX2009000347A (enExample)
MY (1) MY158100A (enExample)
NO (1) NO20090598L (enExample)
NZ (1) NZ574711A (enExample)
WO (1) WO2008008770A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960397B2 (en) * 2007-12-28 2011-06-14 Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
EP2845856A1 (en) 2009-06-29 2015-03-11 Incyte Corporation Pyrimidinones as PI3K inhibitors
WO2011075630A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
US8759359B2 (en) * 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
EP2558463A1 (en) 2010-04-14 2013-02-20 Incyte Corporation Fused derivatives as i3 inhibitors
EP2395086A1 (en) * 2010-06-09 2011-12-14 Chanel Parfums Beauté Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
EP2711422B1 (en) * 2010-06-09 2014-10-01 Chanel Parfums Beauté Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
TW201249844A (en) 2010-12-20 2012-12-16 Incyte Corp N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
UA121539C2 (uk) 2011-09-02 2020-06-25 Інсайт Холдинґс Корпорейшн Гетероцикліламіни як інгібітори рі3к
US20130072506A1 (en) 2011-09-16 2013-03-21 Lenka ZAHAJSKA 6,8-disubstituted purine compositions
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
CZ306984B6 (cs) * 2014-12-15 2017-11-01 Ústav experimentální botaniky AV ČR, v. v. i. 6,8-Disubstituované-9-(heterocyklyl)puriny, přípravky obsahující tyto deriváty a jejich použití v kosmetických a medicínských aplikacích
UA122332C2 (uk) 2015-02-27 2020-10-26 Інсайт Корпорейшн Солі інгібітора pi3k і способи їх отримання
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
CZ307722B6 (cs) * 2015-08-28 2019-03-27 Univerzita PalackĂ©ho v Olomouci Adeninové deriváty a jejich použití
CZ307868B6 (cs) 2017-04-28 2019-07-10 Univerzita PalackĂ©ho v Olomouci Deriváty 9-(2-oxacykloalkyl)-9H-purin-2,6-diaminu, přípravky obsahující tyto deriváty a jejich použití
MX2020012826A (es) 2018-06-01 2021-03-09 Incyte Corp Regimen de dosificacion para el tratamiento de trastornos relacionados con fosfatidilinositol 3-cinasas (pi3k).
EP4178959B1 (en) 2020-07-13 2025-09-10 Univerzita Palackého v Olomouci Nitrogen heterocyclic cytokinin derivatives, compositions containing these derivatives and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602139A (en) * 1987-02-26 1997-02-11 Senetek Plc Method for ameliorating the adverse effects of aging

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
WO2004037159A2 (en) * 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
NZ546611A (en) * 2003-09-18 2010-02-26 Conforma Therapeutics Corp Novel heterocyclic compounds as HSP90-inhibitors
EP1901817A2 (en) * 2005-07-08 2008-03-26 The Procter and Gamble Company Personal care compositions and methods for the beautification of mammalian skin and hair

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602139A (en) * 1987-02-26 1997-02-11 Senetek Plc Method for ameliorating the adverse effects of aging

Also Published As

Publication number Publication date
MY158100A (en) 2016-08-30
CN101646435A (zh) 2010-02-10
KR20090047457A (ko) 2009-05-12
CN101646435B (zh) 2012-08-22
JP2009543799A (ja) 2009-12-10
IL196442A0 (en) 2009-11-18
EA200970110A1 (ru) 2009-06-30
US20130072505A1 (en) 2013-03-21
CA2657516C (en) 2016-05-10
US20110224238A1 (en) 2011-09-15
AU2007272576A1 (en) 2008-01-17
KR101478727B1 (ko) 2015-01-02
EP2043630A4 (en) 2010-12-29
EP2043630B1 (en) 2016-09-07
MX2009000347A (es) 2009-03-20
EA015848B1 (ru) 2011-12-30
NO20090598L (no) 2009-04-14
BRPI0714161A2 (pt) 2012-12-25
WO2008008770A3 (en) 2008-04-10
WO2008008770A2 (en) 2008-01-17
ES2603216T3 (es) 2017-02-24
IL196442A (en) 2015-10-29
CA2657516A1 (en) 2008-01-17
US20100234401A1 (en) 2010-09-16
JP5309023B2 (ja) 2013-10-09
NZ574711A (en) 2012-05-25
EP2043630A2 (en) 2009-04-08
US20080009508A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
CA2657516C (en) 6,9-disubstituted purine derivatives and their use for treating skin
US5371089A (en) Method and composition for ameliorating the adverse effects of aging
JP5686365B2 (ja) コラーゲン産生促進剤、光老化防止剤、保湿機能改善剤および皮膚用剤組成物
JP2021530447A (ja) 皮膚状態の治療方法
KR20020069482A (ko) 레티노이드 피부 손상의 억제 방법
US6998129B2 (en) Cosmetic or dermatological composition comprising an association between an elastase inhibitor compound of the N-acylaminoamide family and at least one anti-inflammatory compound
US6660251B1 (en) Galenic formulation containing biotin
CN117064776B (zh) 邻甲苯基双胍或其组合物在制备护理产品中的应用
JP5787246B2 (ja) 角化細胞遊走・増殖促進剤を含む、創傷治癒剤および褥瘡（床ずれ）治療薬
JPH07238007A (ja) 毛髪の脱落防止および新毛髪成長刺激方法
CA2108369C (en) Method and composition for ameliorating the adverse effects of aging
EP1651237A2 (en) Methods for treatment of dermatological conditions
KR101792402B1 (ko) 니코틴산 아데닌 디뉴클레오티드 인산 및 그 유도체를 포함하는 발모 또는 육모 촉진제
EP2755977B1 (en) 6,8-disubstituted purine compositions and their pharmaceutical and cosmetic use
KR100499190B1 (ko) 육모제
JPWO2001045697A1 (ja) 皮膚外用剤及び薬剤
CN117297999A (zh) 一种改善皮肤状态的组合物及其应用
HK1140425A (en) 6,9-disubstituted purine derivatives and their use for treating skin
CN119970543A (zh) 酒渣碱的美容应用
JP2001508789A (ja) 皮膚の生態と適合性の化粧料用又は皮膚医薬用製品
JPH06505255A (ja) 皮膚病治療薬の調製へのテトラヒドロ−チエノピリドインドール誘導体の使用
JPH1192341A (ja) 毛髪成長期延長剤
JPH09315947A (ja) 育毛剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired